The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > The Immune Response Corporation

The Immune Response Corporation
Nasdaq: IMNR
Change
symbol:
     
 PROFILE
Development-stage firm Immune Response is focused on bringing to market Remune, an injectable immune-based therapy designed by Jonas Salk (inventor of the polio vaccine) to slow or stop the progression of HIV into AIDS. The company's collaborative deal with Pfizer subsidiary Agouron Pharmaceuticals has been terminated, with Immune Response regaining full marketing rights for Remune (should it be approved by the FDA). The company is also developing therapies for other autoimmune conditions -- psoriasis, rheumatoid arthritis, multiple sclerosis -- and some cancers. In addition, it is researching a technology to deliver gene therapy to liver cells as a treatment for such diseases as hemophilia A and hepatitis B.

 COMPETITION
Abbott Laboratories (ABT)
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 7.40
1-Yr. Sales Growth: (64.4)%
Employees: 129
Revenue per employee: $57,364.34

 KEY PEOPLE
• Dennis J. Carlo
    CEO
• Howard Sampson
    CFO

 CONTACT INFO
5935 Darwin Ct.
Carlsbad, CA 92008
US
Phone: 760-431-7080
Fax: 760-431-8636
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001